Minerva Neurosciences | NERV - Rentabilidad Por Dividendo





Dy Cambio Fecha
Alterity Therapeutics Limited AUD 0 0 2024-12
AstraZeneca USD 1.75 0.57 2026-06
BioCryst Pharmaceuticals 0 0 2025-03
Bristol-Myers Squibb 4.36 0.23 2026-06
Cipla 0.89 0.18 2026-06
Clal Biotechnology 0 0 2022-08
Compugen USD 0 0 2024-05
CSL USD 2.53 0.78 2025-12
Eli Lilly 0.56 0.02 2026-06
GlaxoSmithKline 0.86 0.03 2026-06
Grifols EUR 1.88 0.68 2025-12
J&J 2.06 0.1 2026-06
Merck 2.62 0.14 2026-06
Minerva Neurosciences 0 0 2025-03
Novartis USD 3.1 0.23 2026-06
Pfizer 7.08 0.72 2026-06
Roche Holding 2.94 0.01 2026-06
Sanofi 5.49 0.51 2026-06
Takeda 3.88 2.23 2026-06
Vanda Pharmaceuticals 0 0 2025-03